Results 121 to 130 of about 120,357 (292)

Potential Survival Benefit of Neoadjuvant Docetaxel, Cisplatin and 5‐Fluorouracil Therapy in Patients With Esophageal Squamous Cell Carcinoma With Multiple Lymph Node Metastases: A Single‐Institute Propensity Score Analysis

Annals of Gastroenterological Surgery, EarlyView.
Although neoadjuvant chemotherapy with fluorouracil, cisplatin, and docetaxel (NAC‐DCF) is the current standard neoadjuvant regimen for esophageal squamous cell carcinoma, its substantial toxicity underscores the need to identify patients who derive the greatest benefit.
Eiji Higaki, Tetsuya Abe, Hironori Fujieda, Shigenori Kadowaki, Tsutomu Tanaka, Masahiro Tajika, Koji Komori, Seiji Ito, Isao Oze, Kei Muro   +9 more
wiley   +1 more source

Prevalence of Eosinophilic Esophagitis Among Ethnic Groups in a Private vs a Safety Net-Hospital in Southern California

Gastro Hep Advances
Background and Aims: Eosinophilic esophagitis (EoE) is rapidly increasing in incidence and prevalence. It is more prevalent among Whites as compared to Hispanics. The reasons for this disparity remain unclear. We aimed to compare EoE Prevalence between a
Ibrahim Abboud, Susie Lee, Jordan Stellern, Andrew Cruz, Nicholas Placone, Jennifer Dodge, Collin Mayemura, Anisa Shaker, Edy Soffer   +8 more
doaj   +1 more source

Clinical Significance of PD‐L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy

Annals of Gastroenterological Surgery, EarlyView.
This study evaluated immune‐related biomarkers in esophageal squamous cell carcinoma treated with immune checkpoint inhibitors after postoperative recurrence. PD‐L1 expression in tumor‐associated macrophages and tumor cells, together with HLA class I downregulation and HLA‐DR expression, were associated with favorable responses to immunotherapy.
Kosuke Kanemitsu, Yoshiyuki Tagayasu, Yoshihiro Komohara, Cheng Pan, Rin Yamada, Yukio Fujiwara, Kazuto Harada, Keisuke Kosumi, Yoshifumi Baba, Masaaki Iwatsuki   +9 more
wiley   +1 more source

The Predilection of Specific Diseases to Affect Different Sections of the Esophagus

Life
Certain esophageal diseases have a predilection for affecting different parts of the esophagus. This predilection is noted in our clinical practice as we investigate various esophageal diseases using multiple imaging and motility studies, as well as ...
Monjur Ahmed
doaj   +1 more source

Eosinophilic Esophagitis: A Primary Disease of the Esophageal Mucosa [PDF]

The Journal of Allergy and Clinical Immunology: In Practice, 2017
J Pablo, Abonia, Jonathan M, Spergel, Antonella, Cianferoni   +2 more
openaire   +2 more sources

Relationship Between Hospital Volume and Outcomes of Minimally Invasive Esophagectomy for Esophageal Cancer: Analysis of the National Clinical Database in Japan

Annals of Gastroenterological Surgery, EarlyView.
According to multivariable analysis conducted using a hierarchical logistic regression model, using VHH as the reference group, the odds ratios for mortality by hospital volume category were as follows: VLH, 2.70 (p < 0.0001); LH, 1.72 (p = 0.052); MH, 1.70 (p = 0.034); and HH, 1.43 (p = 0.173).
Soji Ozawa, Hiraku Kumamaru, Yuko Kitagawa, Kazuo Koyanagi, Junya Oguma, Harushi Udagawa, Hiroaki Miyata, Yasushi Toh, Hisahiro Matsubara   +8 more
wiley   +1 more source

Systematic Review and Meta‐Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma

Annals of Gastroenterological Surgery, EarlyView.
This meta‐analysis of 208 cases shows that salvage esophagectomy for cT4 esophageal squamous cell carcinoma achieves a 72% R0 resection rate, offering a curative pathway for selected patients. However, it remains a high‐risk procedure with an 18% anastomotic leak rate and 30% major complications (Clavien–Dindo ≥ III).
Makoto Sakai, Kengo Kuriyama, Kazue Nagai, Ken Shirabe, Hiroshi Saeki   +4 more
wiley   +1 more source

Innovations in Gastric Cancer Surgery During Early Minimally Invasive Era and Future Perspectives

Annals of Gastroenterological Surgery, EarlyView.
With continuing revelations in tumor biology and the emergence of artificial intelligence, new horizons for surgical innovation are opening. At the center of this transformative journey stands the innovative surgeon, driven by passion, guided by data, and steadfast in the commitment to patient safety and quality of life.
Reut El‐On, Young‐Woo Kim
wiley   +1 more source

Table_1_The causal relationship between COVID-19 and ten esophageal diseases: a study utilizing Mendelian randomization.XLSX

BackgroundClinical signs of dysphagia, pancreatic achalasia, and esophagitis have been reported in patients with COVID-19. However, the causal relationship between COVID-19 and esophageal diseases is not clear.
Xiang Gao (4077), Jingxiao Li (2620345), Guiyu Feng (12424452), Yue Li (102191), Longqian Wei (18472119), Jun Liu (42548), Huafu Zhou (155353), Xu He (685343), Guanqiang Yan (18472116), Guosheng Li (1419298)   +9 more
core   +1 more source

Safety of endoscopic removal of self-expandable stents after treatment of benign esophageal diseases

, 2013
Temporary placement of self-expandable stents has been increasingly used for the management of benign esophageal diseases. To evaluate the safety of endoscopic removal of esophageal self-expandable stents placed for the treatment of benign esophageal ...
Fleischer, David E., Dijkgraaf, Marcel G. W., van Halsema, Emo E., Rando, Giacomo, Ginsberg, Gregory G., van Hooft, Jeanin E., Baron, Todd H., Shah, Pari M., Siersema, Peter D., Wong Kee Song, Louis M., Ratuapli, Shiva K., Vleggaar, Frank P., Fockens, Paul, Repici, Alessandro   +13 more
core   +1 more source